A double-blind, fixed-dose study of escitalopram in adult patients with major depressive disorder.
Phase of Trial: Phase III
Latest Information Update: 12 May 2010
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Registrational; Therapeutic Use
- Sponsors Forest Laboratories
- 07 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 May 2010 Actual patient number (877) added as reported by ClinicalTrials.gov.
- 22 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.